SAVE THE DATE!
……………
September 26-29, 2021
Montreal, QC, Canada
Hybrid Meeting
The Society is currently planning to host the 2021 annual meeting in person in Montreal, Quebec in addition to having the option to attend and participate virtually. Details will be forthcoming as possibilities for in-person meetings are still TBD due to COVID-19.
Abstract Submission Deadlines
Short Talks & Awards – July 9, 2021
Posters – August 7, 2021
Organizing Committee
Co-Chairs:
Daniel O’Reilly, PhD, RNA Therapeutics Institute, UMass Medical School
Ronald Buijsen, PhD, Leiden University Medical Center
Joseph Ochaba, PhD, Ionis Pharmaceuticals
Erin M. McConnell, PhD, University of Ottawa
Committee Members:
Annemieke Aartsma-Rus, PhD, Leiden University Medical Center
Leonora Abdullahu, McGill University
Shalini Anderson, PhD, AstraZeneca
Annabelle Biscans, PhD, AstraZeneca
David Corey, PhD, UT Southwestern
Masad J. Damha, PhD, FCIC, McGill University
Keith Gagnon, PhD, Southern Illinois University
Bruno Godhino, PhD, Atalanta Therapeutics
Holly Kordasiewicz, PhD, Ionis Pharmaceuticals
Aurélie Lacroix, PhD, Sixfold Biosciences
Marc Lemaitre, PhD, ML_Consult
Martin Maier, PhD, Alnylam Pharmaceuticals
John Maraganore, PhD, Alnylam Pharmaceuticals
Mano Manoharan, PhD, Alnylam Pharmaceuticals
Jimmy Weterings, PhD, AstraZeneca
Tim Yu, PhD, Boston Children’s Hospital, Harvard University